Patexia Community

Innovation, Technology, and IP News

Patexia Insight 179: Best Patent Litigators of 2023: A Fusion of Analytics and Peer Reviews

In January, we delved into the intricacies of patent litigation in our third annual Patent Litigation Intelligence Report. This comprehensive study spanned five years, from July 1...

Fresh From the Bench: Latest Precedential Patent Case

CASE OF THE WEEK Medtronic, Inc. et al. v. Teleflex Innovations S.A.R.L., Appeal Nos. 2021-2356, -2358, -2361, -2363, and -2365 (Fed. Cir. May 24, 2023) In this week’s Case of...

ANDA Litigation: Navigating the Complexities of Patents and Generic Drug Approvals

In the world of pharmaceuticals, the Abbreviated New Drug Application (ANDA) process plays a critical role in the approval and market entry of generic drugs. However, the intersection...

FDA Approves Qalsody™ for Treatment of ALS

Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the...

Brain Computer Interface Developer Announces $33M Series A, Granted FDA “Breakthrough” Designation

Written by:Tom Cowan Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A funding round as well as a...

Feed tagged as "biotechnology":

FDA Approves Qalsody™ for Treatment of ALS

Knobbe Martens 6 days ago

Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA)... Read More »

Comment: 0 Favorite (0)

Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy

Knobbe Martens May 22, 2023

Written by: Sophia Petrichenko & Jason J. Jardine As predictions of an economic recession in the United States loom, 2023 has... Read More »

Comment: 0 Favorite (0)

Implications of the Proposed EU Pharmaceutical Law Reform Overhaul

Knobbe Martens May 10, 2023

Written by:Nima Zargari, Ph.D. & Joseph Mallon, Ph.D. On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »

Comment: 0 Favorite (0)

Supreme Court Issues Stay in Mifepristone Case, Preserving Status Quo for Now

Knobbe Martens Apr 28, 2023

Written by: Alistair J. McIntyre & Jane Dai, Ph.D. On April 21, 2023, the Supreme Court granted a ... Read More »

Comment: 0 Favorite (0)

A Patent for Controlling Access to Drugs Is Not Listable in the Orange Book

Knobbe Martens Apr 14, 2023

Written by: Blake A. Winn & Jason J. Jardine The “Orange Book”, more formally known as Approved Drug Products with... Read More »

Comment: 0 Favorite (0)

Federal Circuit Finds Patent for Dietary Supplements Invalid Under § 101 for Reciting Naturally Occurring Milk Components

Knobbe Martens Apr 14, 2023

Written by: Ashley C. Morales & Michael L. Fuller In ChromaDex, Inc. v Elysium Health, Inc., Appeal No. 2022-1116, the Federal... Read More »

Comment: 0 Favorite (0)

Incorporation by Reference: Patent Portfolio Builder or Destroyer?

Knobbe Martens Apr 12, 2023

Written by: Zachary B. Messick & Douglas B. Wentzel ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC. Before Reyna, Schall, ... Read More »

Comment: 0 Favorite (0)

Teva v. GSK: The “Skinny” Label Case Pending Before the Supreme Court

Knobbe Martens Apr 10, 2023

Written by: Ari Feinstein & Agnes Juang, Ph.D. On March 29, 2023, the Solicitor General of the United States asked the Supreme... Read More »

Comment: 0 Favorite (0)

Description Prescription

Knobbe Martens Mar 6, 2023

Written by: Brandon D. Hupka & Hans L. Mayer REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC. Before... Read More »

Comment: 0 Favorite (0)

BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda

Knobbe Martens Jan 23, 2023

Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in... Read More »

Comment: 0 Favorite (0)

Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?

Mikele Bicolli Aug 28, 2022

Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »

Comment: 0 Favorite (0)

Expert Testimony That Contradicts Patent Specification Fails to Create a Genuine Issue of Fact in a Patent Eligibility Dispute

Knobbe Martens Jul 21, 2022

CAREDX, INC. V. NATERA, INC. Before Lourie, Bryson, and Hughes Summary: Expert testimony that steps of challenged patent claims... Read More »

Comment: 0 Favorite (0)

Patenting Small and Large Molecule Drugs

Mikele Bicolli Jul 13, 2022

Small molecule drugs have been the norm for much of medicine’s history. Only in the past decade has there been a rise ... Read More »

Comment: 0 Favorite (0)

No Standing in IPR Appeal for Sublicensee’s Speculative Royalty-Based Injuries

Knobbe Martens Dec 3, 2021

MODERNATX, INC. v. ARBUTUS BIOPHARMA CORPORATION Before Lourie, O’Malley, and Stoll. Appeal from the Patent Trial and Appeal Board. Summary... Read More »

Comment: 0 Favorite (0)

Ranges for Interdependent and Interactive Components Can Be Tricky to Derive

Knobbe Martens Dec 2, 2021

MODERNATX, INC. v. ARBUTUS BIOPHARMA CORPORATION Before Lourie, O’Malley and Stoll. Appeal from the Patent Trial and Appeal Board. Summary... Read More »

Comment: 0 Favorite (0)

Billion Dollar Verdict Erased by Inadequate Description of Functional Claims

Knobbe Martens Aug 30, 2021

JUNO THERAPEUTICS, INC. v. KITE PHARMA, INC. Before Moore, Prost, and O’Malley. Appeal from the United States District Court for the Central District of... Read More »

Comment: 0 Favorite (0)

Presumption of Nexus Between Claims and Commercial Products May Not Apply When Unclaimed Features Are Critical

Knobbe Martens Aug 17, 2021

TEVA PHARMACEUTICALS v. ELI LILLY AND COMPANY Before LOURIE, BRYSON, and O’MALLEY. Appeal from the Patent Trial and Appeal Board. Summary: The... Read More »

Comment: 0 Favorite (0)

“Some” Enablement Isn’t Enough For PacBio

Knobbe Martens May 12, 2021

PACIFIC BIOSCIENCES OF CALIFORNIA v. OXFORD NANOPORE TECHNOLOGIES Before Lourie, Taranto, and Stoll. Appeal from the United States District Court for the... Read More »

Comment: 0 Favorite (0)

Expiration of Patent Does Not Always Trigger Application of Phillips Standard on IPR Appeal

Knobbe Martens Oct 16, 2020

MMUNEX CORPORATION v. SANOFI-AVENTIS U.S. LLC Before Prost, Reyna, and Taranto. Appeal from the Patent Trial and Appeal Board. Summary: Expiration of a... Read More »

Comment: 0 Favorite (0)

Claims Covering Human Engineering That Exploits a Naturally-Occurring Phenomenon Are Patent Eligible

Knobbe Martens Aug 7, 2020

ILLUMINA, INC. v. ARIOSA DIAGNOSTICS, INC. Before Lourie, Moore, and Reyna. Modified opinion following Ariosa rehearing petition. Summary: The Federal Circuit ... Read More »

Comment: 0 Favorite (0)

Show more Newsfeed posts